Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Apo-Levocarb (carbidopa-levodopa) Treatment Report
What is Apo-Levocarb?

Apo-Levocarb® is a Canadian brand name for the combination of carbidopa and levodopa. It is used for the treatment of Parkinson's disease and syndrome.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat Parkinson's 3 1
Other 1 0
Slowness 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

  75 mg daily 300 mg daily 4 x 25 mg-100 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Apo-Levocarb (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
1 100% Doctor's advice: 100%

See all 1 patient who’ve stopped taking Apo-Levocarb

Duration See details about how long patients take this treatment ▼

Currently Taking Apo-Levocarb

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
2

Stopped Taking Apo-Levocarb

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.